Seema Sethi

4.6k total citations
90 papers, 3.1k citations indexed

About

Seema Sethi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Seema Sethi has authored 90 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 29 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Seema Sethi's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Seema Sethi is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Seema Sethi collaborates with scholars based in United States, India and China. Seema Sethi's co-authors include Fazlul H. Sarkar, Aamir Ahmad, Dejuan Kong, Wei Chen, Sanjeev Banerjee, Shadan Ali, Yiwei Li, Amro Aboukameel, Zhiwei Wang and Yiwei Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Seema Sethi

87 papers receiving 3.0k citations

Peers

Countries citing papers authored by Seema Sethi

Since Specialization

Citations

This map shows the geographic impact of Seema Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Sethi more than expected).

Fields of papers citing papers by Seema Sethi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seema Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Sethi. The network helps show where Seema Sethi may publish in the future.

Co-authorship network of co-authors of Seema Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of Seema Sethi. A scholar is included among the top collaborators of Seema Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seema Sethi. Seema Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amivantamab plus FOLFOX or FOLFIRI in RAS/BRAF wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study. 2026 ·Journal of Clinical Oncology ·Eric Xueyu Chen, Rozita Abdul Malik, Yu‐Li Su, Pei Jye Voon, (unknown), Dirk Arnold, J. Randolph Hecht, (unknown), (unknown), (unknown), Sreenivasa R Chandana, (unknown), Sanjib Chowdhury, (unknown), (unknown), Mahesh Daksh, (unknown), Seema Sethi, (unknown)	0
2	4O: Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study 2025 ·Journal of Thoracic Oncology ·(unknown), Yoon Jun Kim, SH Lee, B. Liu, (unknown), (unknown), Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Pongwut Danchaivijitr, (unknown), Enriqueta Felip, (unknown), Alexander I. Spira, Benjamin Besse, Tingting Sun, Marguerite Ennis, Seema Sethi, Joshua Bauml, Byoung Chul Cho	14
3	Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again? 2024 ·Biomolecules ·Martin Tobi, (unknown), (unknown), Seema Sethi, Harvinder Talwar, Michael Kam, James S. Hatfield, Edi Levi, Jason J. Hallman, Mary Pat Moyer, Laura A. Kresty, (unknown), Benita L. McVicker	2
4	LBA55 Mechanisms of acquired resistance to first-line amivantamab plus lazertinib versus osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer: An early analysis from the phase III MARIPOSA study 2024 ·Annals of Oncology ·(unknown), SH Lee, Shun Lü, Daniil Stroyakovskiy, (unknown), (unknown), (unknown), Danny Nguyen, James Chih‐Hsin Yang, Maya Gottfried, (unknown), Scott Owen, (unknown), Marguerite Ennis, Seema Sethi, (unknown), J. Zhang, (unknown), (unknown)	19
5	MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer 2021 ·Future Oncology ·Byoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, Michael Thomas, Shun Lü, Benjamin Besse, Tao Sun, Melissa Martínez, Seema Sethi, S. Martin Shreeve, Alexander I. Spira	63
6	Myelolipoma of the Pelvis: A Case Report and Review of Literature 2018 ·Frontiers in Oncology ·Seema Sethi, (unknown), Suzanne M. Jacques, Hussein D. Aoun, (unknown)	6
7	ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways 2012 ·BMC Cancer ·Guohui Wang, Gang Liu, Xiaogang Wang, Seema Sethi, Rouba Ali‐Fehmi, Judith Abrams, Ze Zheng, Kezhong Zhang, Stephen P. Ethier, (unknown)	33
8	Engagement of I-Branching β-1, 6- N -Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF-β Signaling 2011 ·Cancer Research ·Haijun Zhang, Fanyan Meng, (unknown), Bas Kreike, Seema Sethi, Wei Chen, Fred R. Miller, Guojun Wu	70
9	Characteristics and survival of head and neck cancer by HPV status: a cancer registry‐based study 2011 ·International Journal of Cancer ·Seema Sethi, Rouba Ali‐Fehmi, Silvia Franceschi, Linda Struijk, Leen‐Jan van Doorn, Wim Quint, (unknown), (unknown), Ikuko Kato	83
10	Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury 2011 ·Radiotherapy and Oncology ·Gilda G. Hillman, Vinita Singh‐Gupta, (unknown), Christopher K. Yunker, J Rakowski, Fazlul H. Sarkar, Stephen R. Miller, Shirish M. Gadgeel, Seema Sethi, Michael C. Joiner, André Konski	35
11	Dynamic Contrast-Enhanced Magnet Resonance Imaging of Sunitinib-Induced Vascular Changes to Schedule Chemotherapy in Renal Cell Carcinoma Xenograft Tumors 2010 ·Translational Oncology ·Gilda G. Hillman, Vinita Singh‐Gupta, (unknown), Hao Zhang, Christopher K. Yunker, A. Patel, Seema Sethi, Judith Abrams, (unknown)	20
12	The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer 2010 ·Current Pharmaceutical Design ·Fulvio Lonardo, Xiaohua Li, Alexander Kaplun, Ayman O. Soubani, Seema Sethi, Shirish M. Gadgeel, Shijie Sheng	29
13	Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells 2010 ·PLoS ONE ·Dejuan Kong, Sanjeev Banerjee, Aamir Ahmad, Yiwei Li, Zhiwei Wang, Seema Sethi, Fazlul H. Sarkar	328
14	Epigenetic events underlie the pathogenesis of sinonasal papillomas 2007 ·Modern Pathology ·Josena K. Stephen, (unknown), (unknown), Seema Sethi, Veena Shah, Michael S. Benninger, Glendon M. Gardner, Vanessa G. Schweitzer, Mumtaz J. Khan, Maria J. Worsham	28
15	Multinodular keratoacanthoma: a rare but definite entity 2002 ·International Journal of Dermatology ·Kabir Sardana, Rashmi Sarkar, Vijay Kumar Garg, R V Koranne, Ravi C. Sharma, Seema Sethi	3
16	Klippel-Trenaunay syndrome 2001 ·The Indian Journal of Pediatrics ·Seema Sethi, (unknown)	7
17	Lymphatic Filariasis of the Ovary and Mesosalpinx 2001 ·Journal of obstetrics and gynaecology research ·Seema Sethi, (unknown), Usha Singh, (unknown)	13
18	Retroperitoneal ganglioneuroma: Report of a case diagnosed by fine-needle aspiration cytology, with review of the literature 1999 ·Diagnostic Cytopathology ·Manjula Jain, (unknown), Seema Sethi, (unknown), (unknown)	46
19	Diagnostic significance of signet ring cells in fine-needle aspirates of the breast 1997 ·Diagnostic Cytopathology ·Seema Sethi, Ricardo S. Cajulis, S. Tunc Gokaslan, Denise Frias‐Hidvegi, Gordon H. Yu	10
20	Isolated Tubercular Tenosynovitis in Children 1994 ·Journal of Pediatric Orthopaedics ·(unknown), Seema Sethi	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact